查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1592002

体外诊断设备市场：按产品、最终用户划分 - 2025-2030 年全球预测

In-Vitro Diagnostics Instrument Market by Product (Clinical Microbiology, Hematology, Hemostasis), End User (Academic & Research Institutes, Homecare, Hospitals & Diagnostic Laboratories) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年体外诊断设备市场价值为241.8亿美元，预计2024年将达到262.3亿美元，复合年增长率为8.58%，到2030年将达到430.4亿美元。

体外诊断 (IVD) 设备市场包括实验室中使用的各种设备，用于对血液、尿液和组织等样本进行测试，以帮助诊断疾病、监测治疗和预防健康状况。对 IVD 设备的需求源于其提供快速、准确的测试结果的能力，这对于有效的患者管理和降低医疗成本至关重要。研究应用包括临床化学、免疫化学、分子诊断和血液学，最终用途包括医院、学术机构、诊断中心和实验室。关键的成长要素包括慢性病盛行率上升、老年人口不断增长、技术进步以及对个人化医疗的需求。机会比比皆是，包括开发就地检验设备、扩大其在居家医疗环境中的使用，以及整合人工智慧以改善诊断。抓住这些机会的建议包括投资创新解决方案的研发以及建立策略伙伴关係以扩大市场。然而，市场成长面临严格的监管要求、高昂的开发成本和竞争压力等挑战，这可能会限制中小企业的进入并延长新产品的上市时间。需要技术创新的领域包括开发具有成本效益、快速且可携式的诊断工具以及开发分子诊断技术以提高准确性。该市场的特点是竞争格局充满活力，主要企业努力实现技术进步和新产品推出，以获得竞争优势。随着产业转向数位化和互连解决方案，诊断中对资料隐私、互通性和网路安全的重视变得越来越重要。为了在这个不断发展的市场中取得成功，公司应该专注于提高产品可靠性、减少测试时间以及从传统环境中扩展应用程序，以满足广泛的医疗和消费者需求。

主要市场统计
基准年[2023] 241.8亿美元
预测年份 [2024] 262.3亿美元
预测年份 [2030] 430.4亿美元
复合年增长率（%） 8.58%

市场动态：快速发展的体外诊断设备市场的关键市场洞察

供需的动态交互作用正在改变体外诊断设备市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 老年人口增加，慢性病及感染疾病率显着
    • 在已开发地区增加全自动和 POC 设备的引进和可用性
    • 提高对疾病适应症和诊断的认识
  • 市场限制因素
    • 不利的赎回选择
  • 市场机会
    • 有针对性的产品开发和商业化
    • 联合研究和产品开发
  • 市场挑战
    • 严格的监管要求

波特五力：驾驭体外诊断设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解体外诊断设备市场的外部影响

外部宏观环境因素在塑造体外诊断设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解体外诊断设备市场的竞争状况

对体外诊断设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵体外诊断设备市场供应商绩效评估

FPNV 定位矩阵是评估体外诊断设备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘体外诊断设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对体外诊断设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化加剧以及慢性病和感染疾病的蔓延
      • 提高已开发地区全自动和 POC 设备的部署和可用性
      • 提高对疾病征兆和诊断的认识
    • 抑制因素
      • 不利的退款选择
    • 机会
      • 有针对性的产品开发和商业化
      • 联合研究和产品开发
    • 任务
      • 严格的监管要求
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章体外诊断设备市场：副产品

  • 临床微生物学
  • 血液学
  • 止血
  • 免疫化学
  • 分子诊断
  • 照护现场
  • 自我监测血糖值
  • 组织诊断

第七章体外诊断设备市场：依最终用户分类

  • 学术研究所
  • 居家护理
  • 医院和诊断实验室

第八章 北美、南美体外诊断设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区体外诊断设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东、非洲体外诊断设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Accelerate Diagnostics, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerieux SA
  • Diasorin SPA
  • F. Hoffmann-La Roche Ltd.
  • GenomeMe Inc.
  • Grifols SA
  • Hologic, Inc.
  • PerkinElmer Inc.
  • Qiagen NV
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-43127F7279FB

The In-Vitro Diagnostics Instrument Market was valued at USD 24.18 billion in 2023, expected to reach USD 26.23 billion in 2024, and is projected to grow at a CAGR of 8.58%, to USD 43.04 billion by 2030.

The In-Vitro Diagnostics (IVD) Instrument market encompasses a wide range of devices used in laboratories to perform tests on samples such as blood, urine, and tissue, aiding in disease diagnosis, treatment monitoring, and health condition prevention. The necessity of IVD instruments stems from their ability to provide quick and accurate test results, crucial for effective patient management and reducing healthcare costs. Applications include clinical chemistry, immunochemistry, molecular diagnostics, and hematology, with end-use scope spanning hospitals, academic institutions, diagnostic centers, and research laboratories. Key growth influencers include the rising prevalence of chronic diseases, increasing geriatric population, advances in technology, and demand for personalized medicine. Opportunities abound in developing point-of-care testing devices, expanding use in home-care settings, and integrating artificial intelligence for improved diagnostics. Recommendations to seize these opportunities include investing in R&D for innovative solutions and forming strategic partnerships to broaden market reach. However, market growth faces challenges such as stringent regulatory requirements, high development costs, and competitive pressure, which can limit smaller players' entry and longer time-to-market for new products. Areas ripe for innovation include developing cost-effective, rapid, and portable diagnostic tools and exploring molecular diagnostic techniques for enhanced precision. The market is characterized by a dynamic and competitive landscape, with key players striving for technological advancements and newer product launches to gain competitive advantages. Emphasis on data privacy, interoperability, and cybersecurity in diagnostics is increasingly crucial as the industry shifts towards digital and interconnected solutions. To thrive in this evolving market, companies should focus on enhancing product reliability, reducing testing times, and expanding applications beyond traditional settings to suit a wider array of medical and consumer needs.

KEY MARKET STATISTICS
Base Year [2023] USD 24.18 billion
Estimated Year [2024] USD 26.23 billion
Forecast Year [2030] USD 43.04 billion
CAGR (%) 8.58%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In-Vitro Diagnostics Instrument Market

The In-Vitro Diagnostics Instrument Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising geriatric population and significant prevalence of chronic and infectious diseases
    • Increasing adoption and availability of fully automated and POC instruments in developed regions
    • Increased awareness about disease indication & diagnostics
  • Market Restraints
    • Non-favourable reimbursement options
  • Market Opportunities
    • Targeted product development and commercialization
    • Collaborative research and product development
  • Market Challenges
    • Stringent regulatory requirements

Porter's Five Forces: A Strategic Tool for Navigating the In-Vitro Diagnostics Instrument Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In-Vitro Diagnostics Instrument Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In-Vitro Diagnostics Instrument Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In-Vitro Diagnostics Instrument Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In-Vitro Diagnostics Instrument Market

A detailed market share analysis in the In-Vitro Diagnostics Instrument Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In-Vitro Diagnostics Instrument Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In-Vitro Diagnostics Instrument Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In-Vitro Diagnostics Instrument Market

A strategic analysis of the In-Vitro Diagnostics Instrument Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Diagnostics Instrument Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerieux SA, Diasorin S.P.A., F. Hoffmann-La Roche Ltd., GenomeMe Inc., Grifols SA, Hologic, Inc., PerkinElmer Inc., Qiagen N.V., Siemens Healthineers, Sysmex Corporation, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the In-Vitro Diagnostics Instrument Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Clinical Microbiology, Hematology, Hemostasis, Immunochemistry, Molecular Diagnostics, Point-of-Care, Self-Monitoring of Blood Glucose, and Tissue Diagnostics.
  • Based on End User, market is studied across Academic & Research Institutes, Homecare, and Hospitals & Diagnostic Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population and significant prevalence of chronic and infectious diseases
      • 5.1.1.2. Increasing adoption and availability of fully automated and POC instruments in developed regions
      • 5.1.1.3. Increased awareness about disease indication & diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Non-favourable reimbursement options
    • 5.1.3. Opportunities
      • 5.1.3.1. Targeted product development and commercialization
      • 5.1.3.2. Collaborative research and product development
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. In-Vitro Diagnostics Instrument Market, by Product

  • 6.1. Introduction
  • 6.2. Clinical Microbiology
  • 6.3. Hematology
  • 6.4. Hemostasis
  • 6.5. Immunochemistry
  • 6.6. Molecular Diagnostics
  • 6.7. Point-of-Care
  • 6.8. Self-Monitoring of Blood Glucose
  • 6.9. Tissue Diagnostics

7. In-Vitro Diagnostics Instrument Market, by End User

  • 7.1. Introduction
  • 7.2. Academic & Research Institutes
  • 7.3. Homecare
  • 7.4. Hospitals & Diagnostic Laboratories

8. Americas In-Vitro Diagnostics Instrument Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific In-Vitro Diagnostics Instrument Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa In-Vitro Diagnostics Instrument Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accelerate Diagnostics, Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biomerieux SA
  • 6. Diasorin S.P.A.
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. GenomeMe Inc.
  • 9. Grifols SA
  • 10. Hologic, Inc.
  • 11. PerkinElmer Inc.
  • 12. Qiagen N.V.
  • 13. Siemens Healthineers
  • 14. Sysmex Corporation
  • 15. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET RESEARCH PROCESS
  • FIGURE 2. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CLINICAL MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HEMOSTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TISSUE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 107. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET, FPNV POSITIONING MATRIX, 2023